Apoptosis and apoptotic body: disease message and therapeutic target potentials

Bioscience Reports - Tập 39 Số 1 - 2019
Xuebo Xu1, Yueyang Lai1, Zichun Hua2,3,1
1State Key Laboratory of Pharmaceutical Biotechnology, School of Life Sciences, Nanjing University, Nanjing 210023, China
2Changzhou High-Tech Research Institute of Nanjing University and Jiangsu Targetpharma Laboratories Inc., Changzhou, 213164, China;
3Shenzhen Research Institute of Nanjing University, Shenzhen 518057, China

Tóm tắt

AbstractApoptosis is widely known as programmed cell death eliciting no inflammatory responses. The intricacy of apoptosis has been a focus of an array of researches, accumulating a wealth of knowledge which led to not only a better understanding of the fundamental process, but also potent therapies of diseases. The classic intrinsic and extrinsic signaling pathways of apoptosis, along with regulatory factors have been well delineated. Drugs and therapeutic measures designed based on current understanding of apoptosis have long been employed. Small-molecule apoptosis inducers have been clinically used for eliminating morbid cells and therefore treating diseases, such as cancer. Biologics with improved apoptotic efficacy and selectivity, such as recombinant proteins and antibodies, are being extensively researched and some have been approved by the FDA. Apoptosis also produces membrane-bound vesicles derived from disassembly of apoptotic cells, now known as apoptotic bodies (ApoBDs). These little sealed sacs containing information as well as substances from dying cells were previously regarded as garbage bags until they were discovered to be capable of delivering useful materials to healthy recipient cells (e.g., autoantigens). In this review, current understandings and knowledge of apoptosis were summarized and discussed with a focus on apoptosis-related therapeutic applications and ApoBDs.

Từ khóa


Tài liệu tham khảo

Kerr, 2002, History of the events leading to the formulation of the apoptosis concept, Toxicology, 181–182, 471, 10.1016/S0300-483X(02)00457-2

King, 1998, Cell cycle regulation and apoptosis, Annu. Rev. Physiol., 60, 601, 10.1146/annurev.physiol.60.1.601

Cohen, 1997, Caspases: the executioners of apoptosis, Biochem. J., 326, 1, 10.1042/bj3260001

Levine, 1997, p53, the cellular gatekeeper for growth and division, Cell, 88, 323, 10.1016/S0092-8674(00)81871-1

Gozuacik, 2004, Autophagy as a cell death and tumor suppressor mechanism, Oncogene, 23, 2891, 10.1038/sj.onc.1207521

Kerr, 1972, Apoptosis: a basic biological phenomenon with wide-ranging implications in tissue kinetics, Br. J. Cancer, 26, 239, 10.1038/bjc.1972.33

Majno, 1995, Apoptosis, oncosis, and necrosis. An overview of cell death, Am. J. Pathol., 146, 3

Wang, 1997, p53 tumor-suppressor gene: clues to molecular carcinogenesis, J. Cell. Physiol., 173, 247, 10.1002/(SICI)1097-4652(199711)173:2%3c247::AID-JCP30%3e3.0.CO;2-A

Miyashita, 1994, Identification of a p53-dependent negative response element in the bcl-2 gene, Cancer Res., 54, 3131

Russell, 1995, Activation-induced death of mature T cells in the regulation of immune responses, Curr. Opin. Immunol., 7, 382, 10.1016/0952-7915(95)80114-6

Shiver, 1992, Cytotoxicity with target DNA breakdown by rat basophilic leukemia cells expressing both cytolysin and granzyme A, Cell, 71, 315, 10.1016/0092-8674(92)90359-K

Trapani, 2002, Functional significance of the perforin/granzyme cell death pathway, Nat. Rev. Immunol., 2, 735, 10.1038/nri911

Pietenpol, 2002, Cell cycle checkpoint signaling: cell cycle arrest versus apoptosis, Toxicology, 181–182, 475, 10.1016/S0300-483X(02)00460-2

Orlova-Fink, 2017, Preferential susceptibility of Th9 and Th2 CD4+ T cells to X4-tropic HIV-1 infection, AIDS, 31, 2211, 10.1097/QAD.0000000000001630

Garcia-Arriaza, 2017, HIV/AIDS vaccine candidates based on replication-competent recombinant poxvirus NYVAC-C-KC expressing trimeric gp140 and gag-derived virus-like particles or lacking the viral molecule B19 that inhibits type I interferon activate relevant HIV-1-specific B and T cell immune functions in nonhuman primates, J. Virol., 91, 10.1128/JVI.02182-16

Pitti, 1996, Induction of apoptosis by Apo-2 ligand, a new member of the tumor necrosis factor cytokine family, J. Biol. Chem., 271, 12687, 10.1074/jbc.271.22.12687

Pan, 1997, The receptor for the cytotoxic ligand TRAIL, Science, 276, 111, 10.1126/science.276.5309.111

Walczak, 1997, TRAIL-R2: a novel apoptosis-mediating receptor for TRAIL, EMBO J., 16, 5386, 10.1093/emboj/16.17.5386

Takeda, 2001, Involvement of tumor necrosis factor-related apoptosis-inducing ligand in surveillance of tumor metastasis by liver natural killer cells, Nat. Med., 7, 94, 10.1038/83416

Menendez, 2009, The expanding universe of p53 targets, Nat. Rev. Cancer, 9, 724, 10.1038/nrc2730

Zhang, 2005, Mechanisms of resistance to TRAIL-induced apoptosis in cancer, Cancer Gene Ther., 12, 228, 10.1038/sj.cgt.7700792

Yao, 2012, Induction of non-small cell lung carcinoma apoptosis using soluble RGD-TRAIL by targeting the integrin receptor of tumor cells, Mol. Med. Rep., 6, 1355, 10.3892/mmr.2012.1071

Yu, 2014, DR4 specific TRAIL variants are more efficacious than wild-type TRAIL in pancreatic cancer, Cancer Biol. Ther., 15, 1658, 10.4161/15384047.2014.972183

Qiu, 2013, Annexin V-TRAIL fusion protein is a more sensitive and potent apoptotic inducer for cancer therapy, Sci. Rep., 3, 3565, 10.1038/srep03565

Batandier, 2004, Opening of the mitochondrial permeability transition pore induces reactive oxygen species production at the level of the respiratory chain complex I, J. Biol. Chem., 279, 17197, 10.1074/jbc.M310329200

Du, 2000, Smac, a mitochondrial protein that promotes cytochrome c-dependent caspase activation by eliminating IAP inhibition, Cell, 102, 33, 10.1016/S0092-8674(00)00008-8

de Almagro, 2012, The inhibitor of apoptosis (IAP) proteins are critical regulators of signaling pathways and targets for anti-cancer therapy, Exp. Oncol., 34, 200

Garrido, 2006, Mechanisms of cytochrome c release from mitochondria, Cell Death Differ., 13, 1423, 10.1038/sj.cdd.4401950

Susin, 1999, Molecular characterization of mitochondrial apoptosis-inducing factor, Nature, 397, 441, 10.1038/17135

Joza, 2001, Essential role of the mitochondrial apoptosis-inducing factor in programmed cell death, Nature, 410, 549, 10.1038/35069004

Pinkaew, 2017, Fortilin binds IRE1alpha and prevents ER stress from signaling apoptotic cell death, Nat. Commun., 8, 18, 10.1038/s41467-017-00029-1

Ghosh, 2015, Cross-talk between endoplasmic reticulum (ER) stress and the MEK/ERK pathway potentiates apoptosis in human triple negative breast carcinoma cells: role of a dihydropyrimidone, nifetepimine, J. Biol. Chem., 290, 3936, 10.1074/jbc.M114.594028

Humke, 1998, ERICE, a novel FLICE-activatable caspase, J. Biol. Chem., 273, 15702, 10.1074/jbc.273.25.15702

Koenig, 2001, Evidence that caspase-13 is not a human but a bovine gene, Biochem. Biophys. Res. Commun., 285, 1150, 10.1006/bbrc.2001.5315

Presland, 2009, Function of filaggrin and caspase-14 in formation and maintenance of the epithelial barrier, Dermatol. Sin., 27, 1

Slee, 2001, Executioner caspase-3, -6, and -7 perform distinct, non-redundant roles during the demolition phase of apoptosis, J. Biol. Chem., 276, 7320, 10.1074/jbc.M008363200

Tait, 2010, Mitochondria and cell death: outer membrane permeabilization and beyond, Nat. Rev. Mol. Cell Biol., 11, 621, 10.1038/nrm2952

Cory, 2002, The Bcl2 family: regulators of the cellular life-or-death switch, Nat. Rev. Cancer, 2, 647, 10.1038/nrc883

Miyashita, 1994, Tumor suppressor p53 is a regulator of bcl-2 and bax gene expression in vitro and in vivo, Oncogene, 9, 1799

Miyashita, 1995, Tumor-suppressor P53 is a direct transcriptional activator of the human bax gene, Cell, 80, 293, 10.1016/0092-8674(95)90412-3

Michelsen, 2007, The Crohn’s disease associated T cell co-stimulator Tl1a is induced by FC gamma receptor signaling but not by TLR ligands or pro-inflammatory cytokines in human monocytes and dendritic cells, Gastroenterology, 132, A32

Kobayashi, 2005, Spontaneous neutrophil apoptosis and regulation of cell survival by granulocyte macrophage-colony stimulating factor, J. Leukoc. Biol., 78, 1408, 10.1189/jlb.0605289

Wang, 2003, Direct and indirect induction of apoptosis in human mesenchymal stem cells in response to titanium particles, J. Orthop. Res., 21, 697, 10.1016/S0736-0266(02)00241-3

Perniok, 1998, High levels of circulating early apoptic peripheral blood mononuclear cells in systemic lupus erythematosus, Lupus, 7, 113, 10.1191/096120398678919804

Allina, 2006, T cell targeting and phagocytosis of apoptotic biliary epithelial cells in primary biliary cirrhosis, J. Autoimmun., 27, 232, 10.1016/j.jaut.2006.11.004

Clancy, 2006, Impaired clearance of apoptotic cardiocytes is linked to anti-SSA/Ro and -SSB/La antibodies in the pathogenesis of congenital heart block, J. Clin. Invest., 116, 2413

Lleo, 2007, Autophagy: highlighting a novel player in the autoimmunity scenario, J. Autoimmun., 29, 61, 10.1016/j.jaut.2007.06.003

Ruiz-Arguelles, 2007, Apoptosis of melanocytes in vitiligo results from antibody penetration, J. Autoimmun., 29, 281, 10.1016/j.jaut.2007.07.012

Salunga, 2007, Oxidative stress-induced apoptosis of bile duct cells in primary biliary cirrhosis, J. Autoimmun., 29, 78, 10.1016/j.jaut.2007.04.002

Scott, 2001, Phagocytosis and clearance of apoptotic cells is mediated by MER, Nature, 411, 207, 10.1038/35075603

Schrijvers, 2005, Phagocytosis of apoptotic cells by macrophages is impaired in atherosclerosis, Arterioscler. Thromb. Vasc. Biol., 25, 1256, 10.1161/01.ATV.0000166517.18801.a7

Mochizuki, 1996, Histochemical detection of apoptosis in Parkinson’s disease, J. Neurol. Sci., 137, 120, 10.1016/0022-510X(95)00336-Z

Vonmuhlen, 1995, Autoantibodies in the diagnosis of systemic rheumatic diseases, Semin. Arthritis Rheum., 24, 323, 10.1016/S0049-0172(95)80004-2

Gaipl, 2005, Impaired clearance of dying cells in systemic lupus erythematosus, Autoimmun. Rev., 4, 189, 10.1016/j.autrev.2004.10.007

Rieux-Laucat, 2003, Autoimmune lymphoproliferative syndromes: genetic defects of apoptosis pathways, Cell Death Differ., 10, 124, 10.1038/sj.cdd.4401190

Macchi, 2015, Role of inflammation and apoptosis in multiple sclerosis: comparative analysis between the periphery and the central nervous system, J. Neuroimmunol., 287, 80, 10.1016/j.jneuroim.2015.08.016

Sneller, 1997, Clinical, immunologic, and genetic features of an autoimmune lymphoproliferative syndrome associated with abnormal lymphocyte apoptosis, Blood, 89, 1341, 10.1182/blood.V89.4.1341

Watanabe-Fukunaga, 1992, Lymphoproliferation disorder in mice explained by defects in fas antigen that mediates apoptosis, Reprinted from Nature, 356, 314, 10.1038/356314a0

Thompson, 1995, Apoptosis in the pathogenesis and treatment of disease, Science, 267, 1456, 10.1126/science.7878464

Fevrier, 2011, CD4(+) T cell depletion in human immunodeficiency virus (HIV) infection: role of apoptosis, Viruses, 3, 586, 10.3390/v3050586

Abbate, 2006, Acute myocardial infarction and heart failure: role of apoptosis, Int. J. Biochem. Cell B, 38, 1834, 10.1016/j.biocel.2006.04.010

Carson, 1993, Apoptosis and disease, Lancet, 341, 1251, 10.1016/0140-6736(93)91154-E

Sohn, 2007, Apoptosis during negative selection of autoreactive thymocytes, Curr. Opin. Immunol., 19, 510, 10.1016/j.coi.2007.06.001

Adams, 2007, Bcl-2-regulated apoptosis: mechanism and therapeutic potential, Curr. Opin. Immunol., 19, 488, 10.1016/j.coi.2007.05.004

Gustafsson, 2007, Bcl-2 family members and apoptosis, taken to heart, Am. J. Physiol. Cell Physiol., 292, C45, 10.1152/ajpcell.00229.2006

Thornberry, 1998, Caspases: enemies within, Science, 281, 1312, 10.1126/science.281.5381.1312

Hetts, 1998, To die or not to die – an overview of apoptosis and its role in disease, J. Am. Med. Assoc., 279, 300, 10.1001/jama.279.4.300

Lavrik, 2005, Caspases: pharmacological manipulation of cell death, J. Clin. Invest., 115, 2665, 10.1172/JCI26252

Raff, 1998, Cell suicide for beginners, Nature, 396, 119, 10.1038/24055

Wakelee, 2010, Phase I and pharmacokinetic study of lexatumumab (HGS-ETR2) given every 2 weeks in patients with advanced solid tumors, Ann. Oncol., 21, 376, 10.1093/annonc/mdp292

Soria, 2010, Phase 1b study of dulanermin (recombinant human Apo2L/TRAIL) in combination with paclitaxel, carboplatin, and bevacizumab in patients with advanced non-squamous non-small-cell lung cancer, J. Clin. Oncol., 28, 1527, 10.1200/JCO.2009.25.4847

Younes, 2010, A phase 1b/2 trial of mapatumumab in patients with relapsed/refractory non-Hodgkin’s lymphoma, Br. J. Cancer, 103, 1783, 10.1038/sj.bjc.6605987

Micheau, 2003, Induction of TNF receptor I-mediated apoptosis via two sequential signaling complexes, Cell, 114, 181, 10.1016/S0092-8674(03)00521-X

Schulze-Osthoff, 1998, Apoptosis signaling by death receptors, Eur. J. Biochem., 254, 439, 10.1046/j.1432-1327.1998.2540439.x

Meng, 2017, Anti-tumor effects of a recombinant anti-prostate specific membrane antigen immunotoxin against prostate cancer cells, BMC Urol., 17, 14, 10.1186/s12894-017-0203-9

Zhou, 2013, A novel recombinant immunocasp-6 fusion gene specifically and efficiently suppresses HER2-overexpressing osteosarcoma, Oncol. Rep., 29, 276, 10.3892/or.2012.2122

Hockings, 2015, Bid chimeras indicate that most BH3-only proteins can directly activate Bak and Bax, and show no preference for Bak versus Bax, Cell Death Dis., 6, e1735, 10.1038/cddis.2015.105

Prabhu, 2017, Targeting of X-linked inhibitor of apoptosis protein and PI3-kinase/AKT signaling by embelin suppresses growth of leukemic cells, PLoS One, 12, e0180895, 10.1371/journal.pone.0180895

Carter, 2011, XIAP antisense oligonucleotide (AEG35156) achieves target knockdown and induces apoptosis preferentially in CD34+38− cells in a phase 1/2 study of patients with relapsed/refractory AML, Apoptosis, 16, 67, 10.1007/s10495-010-0545-1

Bai, 2014, Small-molecule SMAC mimetics as new cancer therapeutics, Pharmacol. Ther., 144, 82, 10.1016/j.pharmthera.2014.05.007

Park, 2008, Discovery of an orally bioavailable small molecule inhibitor of prosurvival B-cell lymphoma 2 proteins, J. Med. Chem., 51, 6902, 10.1021/jm800669s

Thomas, 2013, Targeting the Bcl-2 family for cancer therapy, Expert Opin. Ther. Targets, 17, 61, 10.1517/14728222.2013.733001

Zhang, 2017, Pazopanib, a novel multi-kinase inhibitor, shows potent antitumor activity in colon cancer through PUMA-mediated apoptosis, Oncotarget, 8, 3289, 10.18632/oncotarget.13753

Zhang, 2013, An update on antitumor activity of naturally occurring chalcones, Evid. Based Complement Alternat. Med., 2013, 815621

Marqus, 2017, Evaluation of the use of therapeutic peptides for cancer treatment, J. Biomed. Sci., 24, 21, 10.1186/s12929-017-0328-x

Ravichandran, 2011, Beginnings of a good apoptotic meal: the find-me and eat-me signaling pathways, Immunity, 35, 445, 10.1016/j.immuni.2011.09.004

Thery, 2002, Exosomes: composition, biogenesis and function, Nat. Rev. Immunol., 2, 569, 10.1038/nri855

Morel, 2011, Cellular mechanisms underlying the formation of circulating microparticles, Arterioscler. Thromb. Vas., 31, 15, 10.1161/ATVBAHA.109.200956

Atkin-Smith, 2015, A novel mechanism of generating extracellular vesicles during apoptosis via a beads-on-a-string membrane structure, Nat. Commun., 6, 10.1038/ncomms8439

Wickman, 2012, How apoptotic cells aid in the removal of their own cold dead bodies, Cell Death Differ., 19, 735, 10.1038/cdd.2012.25

Charras, 2005, Non-equilibration of hydrostatic pressure in blebbing cells, Nature, 435, 365, 10.1038/nature03550

Barros, 2003, Apoptotic and necrotic blebs in epithelial cells display similar neck diameters but different kinase dependency, Cell Death Differ., 10, 687, 10.1038/sj.cdd.4401236

Croft, 2005, Actin-myosin-based contraction is responsible for apoptotic nuclear disintegration, J. Cell Biol., 168, 245, 10.1083/jcb.200409049

Nunez, 2010, Apoptotic volume decrease as a geometric determinant for cell dismantling into apoptotic bodies, Cell Death Differ., 17, 1665, 10.1038/cdd.2010.96

Bortner, 2008, Cationic gradient reversal and cytoskeleton-independent volume regulatory pathways define an early stage of apoptosis, J. Biol. Chem., 283, 7219, 10.1074/jbc.M707809200

Orlando, 2006, Rho kinase regulates fragmentation and phagocytosis of apoptotic cells, Exp. Cell Res., 312, 5, 10.1016/j.yexcr.2005.09.012

Lane, 2005, Active relocation of chromatin and endoplasmic reticulum into blebs in late apoptotic cells, J. Cell Sci., 118, 4059, 10.1242/jcs.02529

Peter, 2008, Migration to apoptotic “find-me” signals is mediated via the phagocyte receptor G2A, J. Biol. Chem., 283, 5296, 10.1074/jbc.M706586200

D’mello, 2009, The urokinase plasminogen activator receptor promotes efferocytosis of apoptotic cells, J. Biol. Chem., 284, 17030, 10.1074/jbc.M109.010066

Gardai, 2006, Recognition ligands on apoptotic cells: a perspective, J. Leukoc. Biol., 79, 896, 10.1189/jlb.1005550

Kinchen, 2008, A pathway for phagosome maturation during engulfment of apoptotic cells, Nat. Cell Biol., 10, 556, 10.1038/ncb1718

Gerke, 2002, Annexins: from structure to function, Physiol. Rev., 82, 331, 10.1152/physrev.00030.2001

Yang, 2001, In vivo and in vitro measurement of apoptosis in breast cancer cells using Tc-99m-EC-annexin V, Cancer Biother. Radiopharm., 16, 73, 10.1089/108497801750096087

Rottey, 2007, Tc-99m-HYNIC Annexin-V imaging of tumors and its relationship to response to radiotherapy and/or chemotherapy, Q. J. Nucl. Med. Mol. Imaging, 51, 182

Kurihara, 2008, Imaging and dosimetry of Tc-99m EC annexin V: preliminary clinical study targeting apoptosis in breast tumors, Appl. Radiat. Isot., 66, 1175, 10.1016/j.apradiso.2008.01.012

Orlando, 2006, Rho kinase regulates phagocytosis, surface expression of GlcNAc, and Golgi fragmentation of apoptotic PC12 cells, Exp. Cell Res., 312, 3298, 10.1016/j.yexcr.2006.06.033

Witasp, 2007, Bridge over troubled water: milk fat globule epidermal growth factor 8 promotes human monocyte-derived macrophage clearance of non-blebbing phosphatidylserine-positive target cells, Cell Death Differ., 14, 1063, 10.1038/sj.cdd.4402096

Buzas, 2014, Emerging role of extracellular vesicles in inflammatory diseases, Nat. Rev. Rheumatol., 10, 356, 10.1038/nrrheum.2014.19

Moss, 2006, A novel role for microtubules in apoptotic chromatin dynamics and cellular fragmentation, J. Cell Sci., 119, 2362, 10.1242/jcs.02959

Holmgren, 1999, Horizontal transfer of DNA by the uptake of apoptotic bodies, Blood, 93, 3956, 10.1182/blood.V93.11.3956.411k05_3956_3963

Bergsmedh, 2001, Horizontal transfer of oncogenes by uptake of apoptotic bodies, Proc. Natl. Acad. Sci. U.S.A., 98, 6407, 10.1073/pnas.101129998

Zernecke, 2009, Delivery of microRNA-126 by apoptotic bodies induces CXCL12-dependent vascular protection, Sci. Signal., 2, ra81, 10.1126/scisignal.2000610

Halicka, 2000, Segregation of RNA and separate packaging of DNA and RNA in apoptotic bodies during apoptosis, Exp. Cell Res., 260, 248, 10.1006/excr.2000.5027

Turiak, 2011, Proteomic characterization of thymocyte-derived microvesicles and apoptotic bodies in BALB/c mice, J. Proteomics, 74, 2025, 10.1016/j.jprot.2011.05.023

Lleo, 2014, Shotgun proteomics: identification of unique protein profiles of apoptotic bodies from biliary epithelial cells, Hepatology, 60, 1314, 10.1002/hep.27230

Casciola-Rosen, 1994, Autoantigens targeted in systemic lupus erythematosus are clustered in two populations of surface structures on apoptotic keratinocytes, J. Exp. Med., 179, 1317, 10.1084/jem.179.4.1317

Tran, 2002, Subcellular redistribution of la/SSB autoantigen during physiologic apoptosis in the fetal mouse heart and conduction system: a clue to the pathogenesis of congenital heart block, Arthritis Rheum., 46, 202, 10.1002/1529-0131(200201)46:1%3c202::AID-ART10062%3e3.0.CO;2-Y

Berda-Haddad, 2011, Sterile inflammation of endothelial cell-derived apoptotic bodies is mediated by interleukin-1alpha, Proc. Natl. Acad. Sci. U.S.A., 108, 20684, 10.1073/pnas.1116848108

Rubartelli, 1997, The selective engulfment of apoptotic bodies by dendritic cells is mediated by the alpha(v)beta3 integrin and requires intracellular and extracellular calcium, Eur. J. Immunol., 27, 1893, 10.1002/eji.1830270812

Albert, 1998, Dendritic cells acquire antigen from apoptotic cells and induce class I-restricted CTLs, Nature, 392, 86, 10.1038/32183

Li, 2014, Anti-inflammatory response following uptake of apoptotic bodies by meningothelial cells, J. Neuroinflammation, 11, 35, 10.1186/1742-2094-11-35

Kogianni, 2008, Apoptotic bodies convey activity capable of initiating osteoclastogenesis and localized bone destruction, J. Bone Miner. Res., 23, 915, 10.1359/jbmr.080207

Schiller, 2008, Autoantigens are translocated into small apoptotic bodies during early stages of apoptosis, Cell Death Differ., 15, 183, 10.1038/sj.cdd.4402239

Jiang, 2009, Apoptotic body engulfment by hepatic stellate cells promotes their survival by the JAK/STAT and Akt/NF-kappa B-dependent pathways, J. Hepatol., 51, 139, 10.1016/j.jhep.2009.03.024

Marin-Gallen, 2010, Dendritic cells pulsed with antigen-specific apoptotic bodies prevent experimental type 1 diabetes, Clin. Exp. Immunol., 160, 207, 10.1111/j.1365-2249.2009.04082.x

Singh, 2012, Tubular cell HIV-entry through apoptosed CD4 T cells: a novel pathway, Virology, 434, 68, 10.1016/j.virol.2012.09.009

Kranich, 2010, Engulfment of cerebral apoptotic bodies controls the course of prion disease in a mouse strain-dependent manner, J. Exp. Med., 207, 2271, 10.1084/jem.20092401

Samos, 2006, Circulating nucleic acids in plasma/serum and tumor progression – are apoptotic bodies involved? An experimental study in a rat cancer model, Ann. N. Y. Acad. Sci., 1075, 165, 10.1196/annals.1368.022

Bergsmedh, 2001, Horizontal transfer of oncogenes by uptake of apoptotic bodies, Proc. Natl. Acad. Sci. U.S.A., 98, 6407, 10.1073/pnas.101129998

Wiley, 2006, Immature dendritic cell-derived exosomes can mediate HIV-1 trans infection, Proc. Natl. Acad. Sci. U.S.A., 103, 738, 10.1073/pnas.0507995103

Izquierdo-Useros, 2010, HIV and mature dendritic cells: Trojan exosomes riding the Trojan horse?, PLoS Pathog., 6, 10.1371/journal.ppat.1000740

Poon, 2014, Unexpected link between an antibiotic, pannexin channels and apoptosis, Nature, 507, 329, 10.1038/nature13147

Poon, 2014, Apoptotic cell clearance: basic biology and therapeutic potential, Nat. Rev. Immunol., 14, 166, 10.1038/nri3607